Penn State University, Hershey, PA, US
Cancer Biology & Therapy publishes original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. In addition, Cancer Biology & Therapy includes timely reviews, OP-ED pieces and meeting reports that lie within the broad scope of the journal and the expertise of the Editorial Board.
The goal of Cancer Biology & Therapy is to foster communication and rapid exchange of information through expedient publication of important results using traditional as well as electronic formats.
The journal and the outstanding Editorial Board strive to maintain the highest standards of excellence to generate a new and valuable resource for the cancer research community.
If your paper is accepted by Cancer Biology & Therapy it will be published online within two weeks.
Highlights from our most recent issue:
Aurora A mediates post-translational modifications of p53
HDAC inhibitors promote gammaH2AX foci formation
ZIP1/zinc/citrate in TRAMP prostate cancer animal model
Glutamine fuels autophagy in the tumor stroma
Pyruvate kinase expression in cancer associated fibroblasts
CB&T archives (published online for one year or longer) are freely available to all users. Full-text access is available via a link on the abstract page of each paper.
To subscribe to Cancer Biology & Therapy, please contact:
Thomas Ostmeyer, Managing Editor
Landes Bioscience
1806 Rio Grande
Austin, Texas 78701 USA
Email: thomaslandesbioscience.com
http://www.landesbioscience.com/journals/cbt
To submit a manuscript to Cancer Biology & Therapy, please visit http://cbt.msubmit.net